GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » PB Ratio

Remus Pharmaceuticals (NSE:REMUS) PB Ratio : 14.66 (As of Dec. 13, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Remus Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-13), Remus Pharmaceuticals's share price is ₹2500.00. Remus Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2024 was ₹170.55. Hence, Remus Pharmaceuticals's PB Ratio of today is 14.66.

The historical rank and industry rank for Remus Pharmaceuticals's PB Ratio or its related term are showing as below:

NSE:REMUS' s PB Ratio Range Over the Past 10 Years
Min: 9.85   Med: 73.32   Max: 175.28
Current: 14.9

During the past 4 years, Remus Pharmaceuticals's highest PB Ratio was 175.28. The lowest was 9.85. And the median was 73.32.

NSE:REMUS's PB Ratio is ranked worse than
98.04% of 102 companies
in the Medical Distribution industry
Industry Median: 1.235 vs NSE:REMUS: 14.90

During the past 12 months, Remus Pharmaceuticals's average Book Value Per Share Growth Rate was 40.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 250.30% per year.

During the past 4 years, the highest 3-Year average Book Value Per Share Growth Rate of Remus Pharmaceuticals was 250.30% per year. The lowest was 250.30% per year. And the median was 250.30% per year.

Back to Basics: PB Ratio


Remus Pharmaceuticals PB Ratio Historical Data

The historical data trend for Remus Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remus Pharmaceuticals PB Ratio Chart

Remus Pharmaceuticals Annual Data
Trend Mar20 Mar21 Mar22 Mar24
PB Ratio
- - - 11.70

Remus Pharmaceuticals Semi-Annual Data
Mar20 Mar21 Mar22 Sep23 Mar24 Sep24
PB Ratio Get a 7-Day Free Trial - - 10.49 11.70 15.36

Competitive Comparison of Remus Pharmaceuticals's PB Ratio

For the Medical Distribution subindustry, Remus Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Remus Pharmaceuticals's PB Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Remus Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Remus Pharmaceuticals's PB Ratio falls into.



Remus Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Remus Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=2500.00/170.55
=14.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Remus Pharmaceuticals  (NSE:REMUS) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Remus Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of Remus Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Remus Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Ambli bopal Road, 1101 to 1103, South Tower, One 42, Behind Ashok Vatika, Near Jayantilal Park BRTS, Ahmedabad, GJ, IND, 380054
Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.

Remus Pharmaceuticals Headlines

No Headlines